IGF1 and breast carcinoma: For example, a meta-analysis of 34 RCTs in breast cancer patients found significant reductions in insulin-like growth factor 1 (IGF-1), enhancements in muscle strength (e.g., bench and leg press performance), and decreases in BMI and body weight (51).